INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 454m ago
House PTR54m ago
SEC 13F54m ago
Robinhood Chain54m ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
April McClain DelaneyDDependent child
SGISOMNIGROUP INTERNATIONAL INC.
Sale
SELL$100K – $250KAug 25, 2026
Page 153 of 613
← PrevNext →
Sep 9, 2026
traded Aug 25, 2026
+15d
House PTR

Evidence

23
April McClain DelaneyDDependent child
VIKViking Holdings Ltd
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

23
April McClain DelaneyDDependent child
MKLMARKEL GROUP INC.
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

23
April McClain DelaneyDDependent child
SCISERVICE CORP INTERNATIONAL
Sale
SELL$50K – $100KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

23
April McClain DelaneyDDependent child
EMEEMCOR Group, Inc.
Sale
SELL$100K – $250KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

22
DA
Dignan AndyPresident
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$96K
2,900 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
DA
Dignan AndyPresident
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$110K
3,295 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$239K
2,700 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
DA
Dignan AndyPresident
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
4,379 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
AA
Asmerom AmineChief Accounting Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$325K
10.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

22
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$3,240
270 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

22
RG
Russotti GregorySee Remarks
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$1,095
534 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

22
LM
Lee Bryan MChief Financial Officer
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$167K
4,995 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
LM
Lee Bryan MChief Financial Officer
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$215K
6,500 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

22
AA
Asmerom AmineChief Accounting Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$317K
9,505 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

22
WB
Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER
MDRRMedalist Diversified, Inc.
Open-market purchase
BUY$588
49 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

21
April McClain DelaneyDDependent child
LTHLife Time Group Holdings, Inc.
Purchase
BUY$1,001 – $15KAug 6, 2026Sep 9, 2026
traded Aug 6, 2026
+34dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Partial sale
SELL$15K – $50KAug 3, 2026Sep 9, 2026
traded Aug 3, 2026
+37dHouse PTR

Evidence

21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Open-market sale
SELL$43K
1,000 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

21
April McClain DelaneyDDependent child
HUBBHUBBELL INC
Purchase
BUY$1,001 – $15KAug 3, 2026Sep 9, 2026
traded Aug 3, 2026
+37dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
HUBBHUBBELL INC
Purchase
BUY$15K – $50KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
CHRWC. H. ROBINSON WORLDWIDE, INC.
Purchase
BUY$1,001 – $15KAug 5, 2026Sep 9, 2026
traded Aug 5, 2026
+35dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
BWXTBWX Technologies, Inc.
Purchase
BUY$1,001 – $15KAug 3, 2026Sep 9, 2026
traded Aug 3, 2026
+37dHouse PTR

Evidence

21
April McClain DelaneyDDependent child
LTHLife Time Group Holdings, Inc.
Purchase
BUY$1,001 – $15KAug 7, 2026Sep 9, 2026
traded Aug 7, 2026
+33dHouse PTR

Evidence

20
WJ
Wassil JimEVP, Chief Scientific Ofc, COO
PCVXVaxcyte, Inc.
Open-market sale
SELL$79K
1,334 sh
Sep 9, 2026Sep 9, 2026
traded Sep 9, 2026
+0dSEC Form 4

Evidence

20
April McClain DelaneyDDependent child
TDYTELEDYNE TECHNOLOGIES INC
Sale
SELL$15K – $50KAug 25, 2026Sep 9, 2026
traded Aug 25, 2026
+15dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
ESEESCO TECHNOLOGIES INC
Purchase
BUY$1,001 – $15KAug 24, 2026Sep 9, 2026
traded Aug 24, 2026
+16dHouse PTR

Evidence

20
PD
Pfeiffer DeborahEVP & Pres, Presort Services
PBIPITNEY BOWES INC /DE/
Open-market sale · 10b5-1 plan
SELL$342K
20.0K sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

20
April McClain DelaneyDDependent child
TDYTELEDYNE TECHNOLOGIES INC
Partial sale
SELL$1,001 – $15KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
LHLABCORP HOLDINGS INC.
Partial sale
SELL$1,001 – $15KAug 7, 2026Sep 9, 2026
traded Aug 7, 2026
+33dHouse PTR

Evidence

20
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$265K
2,900 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

20
April McClain DelaneyDDependent child
LHLABCORP HOLDINGS INC.
Partial sale
SELL$1,001 – $15KAug 6, 2026Sep 9, 2026
traded Aug 6, 2026
+34dHouse PTR

Evidence

20
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
2,126 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

20
April McClain DelaneyDDependent child
ESEESCO TECHNOLOGIES INC
Purchase
BUY$1,001 – $15KAug 20, 2026Sep 9, 2026
traded Aug 20, 2026
+20dHouse PTR

Evidence

20
April McClain DelaneyDDependent child
MLMMARTIN MARIETTA MATERIALS INC
Purchase
BUY$1,001 – $15KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

20
Maria Elvira SalazarRSelf
MRNAModerna, Inc.
Partial sale
SELL$1,001 – $15KAug 19, 2026Sep 9, 2026
traded Aug 19, 2026
+21dHouse PTR

Evidence

20
AR
Azamian Bobak R.Director, President/CEO and Board Chair
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$641K
7,100 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

20
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$974K
22.8K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

19
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$521
254 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence

17
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$52K
1,803 sh
Sep 8, 2026Sep 9, 2026
traded Sep 8, 2026
+1dSEC Form 4

Evidence